The long-term goal of this research is to elucidate the means by which Epstein-Barr virus (EBV) induces and maintains proliferation of the human B-lymphocytes that it infects. EBV causes or contributes causally to several human diseases of B-lymphocytes including infectious mononucleosis, Burkitt's lymphoma, and lymphomas in immunocompromised patients. It is likely that it does so by causing indefinite proliferation of the B-lymphocytes it infects. It is therefore particularly desirable to understand the process of immortalization of cells by EBV in order to comprehend and eventually to ameliorate the lymphoid diseases associated with EBV. At least three viral proteins, EB nuclear antigens 1 and 2 (EBNA 1 and 2) and the latent membrane protein (LMP) appear to be involved in immortalization. these proteins will be studied to identify their contributions to the process of immortalization. These proteins will be studied to identify their contributions to the process of immortalization. EBNA-1 mediates replication of EBV plasmid DNA and can transactivate transcription. It has been purified so that its intrinsic activities can be identified and analyzed. In particular, its ability to link two DNA molecules to which it binds will be dissected mechanistically in vitro; post-translational modifications that might control its function will be characterized after its isolation from synchronized cells; and cellular proteins with which it interacts to affect transcription will be identified by methods that use crosslinking and by functional tests that employ transcriptional assays in vitro. EBNA-2 affects the transcription of viral and cellular genes variably in different clones of B-lymphoblasts. In order to identify genetic elements affected by EBNA-2 in EBV-immortalized cells, B-lymphoblasts will be engineered to express a chimera of EBNA-2 and a steroid receptor such that the function of EBNA-2 will be dependent upon addition of the steroid. Cis-acting sites that affect viral proteins that are dependent upon function EBNA-2 will be identified and analyzed to find those cellular binding proteins with which EBNA-2 acts to mediate its functions. LMP is likely to contribute to immortalization of cells by EBV by affecting some facet of cellular signaling. An assay in B- lymphoblasts that responds rapidly to LMP will be developed and used to identify pharmacologically specific signaling pathways with which LMP is likely to interact. Experiments that use crosslinking will also be employed to identify cellular proteins that associate with LMP in the expectation that their identification will help to elucidate functions of LMP. Finally the requirement for the continued expression of each of these viral proteins to maintain proliferation of EBV-infected cells will be tested genetically.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Program Projects (P01)
Project #
5P01CA022443-17
Application #
3749337
Study Section
Project Start
Project End
Budget Start
Budget End
Support Year
17
Fiscal Year
1994
Total Cost
Indirect Cost
Name
University of Wisconsin Madison
Department
Type
DUNS #
161202122
City
Madison
State
WI
Country
United States
Zip Code
53715
Weng, Chao; Lee, Denis; Gelbmann, Christopher B et al. (2018) Human Cytomegalovirus Productively Replicates In Vitro in Undifferentiated Oral Epithelial Cells. J Virol 92:
Bristol, Jillian A; Djavadian, Reza; Albright, Emily R et al. (2018) A cancer-associated Epstein-Barr virus BZLF1 promoter variant enhances lytic infection. PLoS Pathog 14:e1007179
Romero-Masters, James C; Ohashi, Makoto; Djavadian, Reza et al. (2018) An EBNA3C-deleted Epstein-Barr virus (EBV) mutant causes B-cell lymphomas with delayed onset in a cord blood-humanized mouse model. PLoS Pathog 14:e1007221
UmaƱa, Angie C; Iwahori, Satoko; Kalejta, Robert F (2018) Direct Substrate Identification with an Analog Sensitive (AS) Viral Cyclin-Dependent Kinase (v-Cdk). ACS Chem Biol 13:189-199
Meyers, Jordan M; Grace, Miranda; Uberoi, Aayushi et al. (2018) Inhibition of TGF-? and NOTCH Signaling by Cutaneous Papillomaviruses. Front Microbiol 9:389
Uberoi, Aayushi; Yoshida, Satoshi; Lambert, Paul F (2018) Development of an in vivo infection model to study Mouse papillomavirus-1 (MmuPV1). J Virol Methods 253:11-17
Djavadian, Reza; Hayes, Mitchell; Johannsen, Eric (2018) CAGE-seq analysis of Epstein-Barr virus lytic gene transcription: 3 kinetic classes from 2 mechanisms. PLoS Pathog 14:e1007114
Chakravorty, Adityarup; Sugden, Bill (2018) Long-distance communication: Looping of human papillomavirus genomes regulates expression of viral oncogenes. PLoS Biol 16:e3000062
Chiu, Ya-Fang; Sugden, Bill (2018) Plasmid Partitioning by Human Tumor Viruses. J Virol 92:
Shin, Myeong-Kyun; Payne, Susan N; Bilger, Andrea et al. (2018) Activating Mutations in Pik3caContribute to Anal Carcinogenesis in the Presence or Absence of HPV-16 Oncogenes. Clin Cancer Res :

Showing the most recent 10 out of 434 publications